HiFiBiO Therapeutics to Present Trial in Progress Poster for HFB301001 at 2022 ESMO Congress Sep 5, 2022 By jeromer
Sep 23, 2021 By sarahjibrin HiFiBiO Therapeutics Contributes to CoVIC-Led Science Publication on SARS-CoV-2 Spike Antibodies Effective Against Variants of Concern
Jun 11, 2021 By sarahjibrin HiFiBiO Therapeutics Announces Publication in Science Advances of its High-Throughput Functional Screening for Next-Generation Cancer Immunotherapy
May 11, 2021 By sarahjibrin HiFiBiO Therapeutics Announces Publication in Nature Communications on its SARS-CoV-2 Neutralizing Monoclonal Antibody
Mar 19, 2021 By sarahjibrin HiFiBiO and Gustave Roussy Researchers Demonstrate the Contribution of Galectin-9 (Gal-9) in Tumor Immune Escape
Mar 30, 2020 By sarahjibrin Droplet Microfluidic Screening and Sequencing Can Vastly Expand the Universe of New Antibody Therapeutics
Mar 30, 2020 By sarahjibrin High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics
Jun 3, 2019 By sarahjibrin HiFiBiO Therapeutics and Leading Academic Institutions Demonstrate Breakthrough Single-Cell Approach for Novel Biomarker Discovery to Combat Cancer
Oct 12, 2017 By Rick Bowen HiFiBiO and collaborators publish single-cell microfluidics work in Nature Biotechnology
Oct 9, 2017 By Rick Bowen Shared Insights About Guiding Principles of Open Collaboration in Drug Discovery Today From HiFiBiO CEO Liang Schweizer and COO Jeff He
Sep 11, 2017 By Rick Bowen Single-Cell Deep Phenotyping of lgG-Secreting Cells for High-Resolution Immune Monitoring
